It also hopes to coordinate CPG development to prevent redundancy of effort and stimulate consensus (http://www.kdigo.org/). CARI (R. Walker) CARI is the only Asia Pacific regional group currently producing English language
CPGs available on the web. The key aspects are an absolute need for a good evidence base to construct CPGs and the recognition that implementation must be inherent in the process [10]. ISN (W. Couser) The ISN Commission on Global Advancement of Nephrology (ISN-COMGAN) pointed out the focus shifting from emphasis on renal replacement therapy to the “new nephrology”—the early check details detection and prevention of kidney disease Palbociclib order and its cardiovascular consequences [4]. Core outreach programmes are encompassed under
COMGAN [11]. The ISN Fellowship programme now emphasises training in clinical epidemiology and outcomes research. The ISN Continuing Nephrology Education (CNE) programme supports over 50 educational events each year, reaching over 10,000 health-care workers, with an emphasis on early detection and treatment of CKD. The restructured ISN Sister Centre programme supports 40 centre relationships worldwide aimed at progressing the developing centre through to becoming a regional, independent focus for promotion of all aspects of renal health care. The ISN Research and Prevention Committee has developed the programme for detection and Entospletinib mouse management of CKD, hypertension, diabetes and cardiovascular diseases. Diversity
and specificity of CKD in Asia Speakers dealt with CKD in the COMGAN regions, first from the two most populous countries, China and India, then a mix of developing and developed countries of differing sizes and economies. Highlighted was the urgent need to develop strategies to combat CKD, given the huge population of Asia, the high prevalence of CKD and the poor economic state of much of the region. China (W. Chen) A randomly selected population-based screening Baricitinib study in southern China (both rural and urban) showed 10.6% had proteinuria, haematuria or reduced estimated GFR. Independent risk factors were age, hypertension and diabetes. India (V. Jha) CKD, diabetes and hypertension have been identified as increasing in prevalence in several small surveys. Diabetes is the commonest cause of end-stage renal diseases (ESRD); 73% of ESRD patients present less than 3 months before diagnosis [12]. Korea (H. J. Chin) A nationwide survey from health checks in 39 hospitals indicated a prevalence of CKD stages 1, 2, 3 or more of 1.39, 3.64 and 2.67%, respectively, with very similar risk factors to Western countries, and a particularly high prevalence in the elderly. Nepal (S. K. Sharma) In this country, where renal replacement therapy (RRT) cannot be afforded, a door-to-door screening and intervention programme was conducted. Of 3,218 people over 20, CKD was detected in 10.6%.